Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Provision for income tax	$ 14	$ 9	$ 43	$ 19
Effective income tax rate	0.20%	0.10%	0.20%	0.10%

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.